Johnson & Johnson’s Spravato Offers Hope for Treatment-Resistant Depression
Nearly 21 million adults in the United States experience clinical depression or major depressive disorder. For many, traditional treatments such…
Étiquette : Spravato
PBS adds Spravato for treatment-resistant depression
Starting May 1, 2025, Australians suffering from treatment-resistant depression will gain access to Spravato (esketamine), a new nasal spray treatment…
French 
English 
German 
Russian 
Spanish 
Belarusian 
Ukrainian